Zydus Lifesciences Limited · Healthcare
$1,160.00
-9.8%
Sep 19, 2026
D
WeakGraded against ZYDUSLIFE's own history at this drawdown — not the market's.
What it means: ZYDUSLIFE's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers active pharmaceutical ingredients, finished dosage formulations, generics, specialty, biosimilars, vaccines, novel products, consumer wellness and animal health products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: ZYDUSLIFE is 9.8% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
Zydus Lifesciences Ltd. (ZYDUSLIFE) sits 9.8% off its peak and is currently in a shallow pullback, last printing at $1,160. Shallow pullbacks like this are routine — historically Indian Stocks assets revisit a 5-10% dip several times a year, and most resolve back to highs within weeks.
History at this drawdown level is well-populated for ZYDUSLIFE — 677 confirmed observations in the 10%-to-5% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in indian stocks return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.
Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to ZYDUSLIFE's own volatility history. Shallow pullbacks are where dip-buying frameworks start to pay off, but only marginally. The median forward return in shallow bands is usually positive but not dramatic.
Five tickers closest to ZYDUSLIFE's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for ZYDUSLIFE. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of ZYDUSLIFE's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for ZYDUSLIFE.
Dipsern is research and a second opinion — not a broker. You'd buy ZYDUSLIFE at your own broker.
Analyze ZYDUSLIFE FreeNo credit card required · 5 free analyses per month
Signal computed Sep 19, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.